nodes	percent_of_prediction	percent_of_DWPC	metapath
Penciclovir—Herpes labialis—Epirubicin—liver cancer	0.0685	0.0685	CcSEcCtD
Penciclovir—Herpes labialis—Doxorubicin—liver cancer	0.0634	0.0634	CcSEcCtD
Penciclovir—Leukocytoclastic vasculitis—Sorafenib—liver cancer	0.0549	0.0549	CcSEcCtD
Penciclovir—Oral herpes—Epirubicin—liver cancer	0.0422	0.0422	CcSEcCtD
Penciclovir—Oral herpes—Doxorubicin—liver cancer	0.039	0.039	CcSEcCtD
Penciclovir—Renal failure acute—Sorafenib—liver cancer	0.0212	0.0212	CcSEcCtD
Penciclovir—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.0176	0.0176	CcSEcCtD
Penciclovir—Neutropenia—Sorafenib—liver cancer	0.0158	0.0158	CcSEcCtD
Penciclovir—Parosmia—Epirubicin—liver cancer	0.0153	0.0153	CcSEcCtD
Penciclovir—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.0149	0.0149	CcSEcCtD
Penciclovir—Hepatobiliary disease—Sorafenib—liver cancer	0.0142	0.0142	CcSEcCtD
Penciclovir—Parosmia—Doxorubicin—liver cancer	0.0142	0.0142	CcSEcCtD
Penciclovir—Rash erythematous—Epirubicin—liver cancer	0.013	0.013	CcSEcCtD
Penciclovir—Erythema multiforme—Sorafenib—liver cancer	0.0128	0.0128	CcSEcCtD
Penciclovir—Cardiac disorder—Sorafenib—liver cancer	0.0125	0.0125	CcSEcCtD
Penciclovir—Rash erythematous—Doxorubicin—liver cancer	0.012	0.012	CcSEcCtD
Penciclovir—Mental disorder—Sorafenib—liver cancer	0.0118	0.0118	CcSEcCtD
Penciclovir—Erythema—Sorafenib—liver cancer	0.0118	0.0118	CcSEcCtD
Penciclovir—Delirium—Epirubicin—liver cancer	0.0116	0.0116	CcSEcCtD
Penciclovir—Dysgeusia—Sorafenib—liver cancer	0.0115	0.0115	CcSEcCtD
Penciclovir—Jaundice cholestatic—Epirubicin—liver cancer	0.0113	0.0113	CcSEcCtD
Penciclovir—Skin discolouration—Epirubicin—liver cancer	0.011	0.011	CcSEcCtD
Penciclovir—Anaemia—Sorafenib—liver cancer	0.0109	0.0109	CcSEcCtD
Penciclovir—Angioedema—Sorafenib—liver cancer	0.0107	0.0107	CcSEcCtD
Penciclovir—Delirium—Doxorubicin—liver cancer	0.0107	0.0107	CcSEcCtD
Penciclovir—Leukopenia—Sorafenib—liver cancer	0.0105	0.0105	CcSEcCtD
Penciclovir—Jaundice cholestatic—Doxorubicin—liver cancer	0.0105	0.0105	CcSEcCtD
Penciclovir—Skin discolouration—Doxorubicin—liver cancer	0.0102	0.0102	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00994	0.00994	CcSEcCtD
Penciclovir—Nervous system disorder—Sorafenib—liver cancer	0.00941	0.00941	CcSEcCtD
Penciclovir—Thrombocytopenia—Sorafenib—liver cancer	0.0094	0.0094	CcSEcCtD
Penciclovir—Skin disorder—Sorafenib—liver cancer	0.00932	0.00932	CcSEcCtD
Penciclovir—Fatigue—Sorafenib—liver cancer	0.00828	0.00828	CcSEcCtD
Penciclovir—Pain—Sorafenib—liver cancer	0.00821	0.00821	CcSEcCtD
Penciclovir—Gastrointestinal pain—Sorafenib—liver cancer	0.00785	0.00785	CcSEcCtD
Penciclovir—Renal failure acute—Epirubicin—liver cancer	0.00782	0.00782	CcSEcCtD
Penciclovir—Urticaria—Sorafenib—liver cancer	0.00763	0.00763	CcSEcCtD
Penciclovir—Abdominal pain—Sorafenib—liver cancer	0.00759	0.00759	CcSEcCtD
Penciclovir—Renal failure acute—Doxorubicin—liver cancer	0.00723	0.00723	CcSEcCtD
Penciclovir—Migraine—Epirubicin—liver cancer	0.0071	0.0071	CcSEcCtD
Penciclovir—Hypersensitivity—Sorafenib—liver cancer	0.00707	0.00707	CcSEcCtD
Penciclovir—Asthenia—Sorafenib—liver cancer	0.00689	0.00689	CcSEcCtD
Penciclovir—Pruritus—Sorafenib—liver cancer	0.00679	0.00679	CcSEcCtD
Penciclovir—Liver function test abnormal—Epirubicin—liver cancer	0.00666	0.00666	CcSEcCtD
Penciclovir—Migraine—Doxorubicin—liver cancer	0.00657	0.00657	CcSEcCtD
Penciclovir—Diarrhoea—Sorafenib—liver cancer	0.00657	0.00657	CcSEcCtD
Penciclovir—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.0065	0.0065	CcSEcCtD
Penciclovir—Dizziness—Sorafenib—liver cancer	0.00635	0.00635	CcSEcCtD
Penciclovir—Liver function test abnormal—Doxorubicin—liver cancer	0.00617	0.00617	CcSEcCtD
Penciclovir—Vomiting—Sorafenib—liver cancer	0.0061	0.0061	CcSEcCtD
Penciclovir—Rash—Sorafenib—liver cancer	0.00605	0.00605	CcSEcCtD
Penciclovir—Dermatitis—Sorafenib—liver cancer	0.00605	0.00605	CcSEcCtD
Penciclovir—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00601	0.00601	CcSEcCtD
Penciclovir—Headache—Sorafenib—liver cancer	0.00601	0.00601	CcSEcCtD
Penciclovir—Neutropenia—Epirubicin—liver cancer	0.00583	0.00583	CcSEcCtD
Penciclovir—Nausea—Sorafenib—liver cancer	0.0057	0.0057	CcSEcCtD
Penciclovir—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00551	0.00551	CcSEcCtD
Penciclovir—Neutropenia—Doxorubicin—liver cancer	0.0054	0.0054	CcSEcCtD
Penciclovir—Hepatobiliary disease—Epirubicin—liver cancer	0.00526	0.00526	CcSEcCtD
Penciclovir—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.0051	0.0051	CcSEcCtD
Penciclovir—Hypoaesthesia—Epirubicin—liver cancer	0.00497	0.00497	CcSEcCtD
Penciclovir—Hepatobiliary disease—Doxorubicin—liver cancer	0.00487	0.00487	CcSEcCtD
Penciclovir—Erythema multiforme—Epirubicin—liver cancer	0.00472	0.00472	CcSEcCtD
Penciclovir—Cardiac disorder—Epirubicin—liver cancer	0.00463	0.00463	CcSEcCtD
Penciclovir—Hypoaesthesia—Doxorubicin—liver cancer	0.0046	0.0046	CcSEcCtD
Penciclovir—Mental disorder—Epirubicin—liver cancer	0.00437	0.00437	CcSEcCtD
Penciclovir—Erythema multiforme—Doxorubicin—liver cancer	0.00437	0.00437	CcSEcCtD
Penciclovir—Erythema—Epirubicin—liver cancer	0.00435	0.00435	CcSEcCtD
Penciclovir—Cardiac disorder—Doxorubicin—liver cancer	0.00429	0.00429	CcSEcCtD
Penciclovir—Flatulence—Epirubicin—liver cancer	0.00428	0.00428	CcSEcCtD
Penciclovir—Dysgeusia—Epirubicin—liver cancer	0.00426	0.00426	CcSEcCtD
Penciclovir—Mental disorder—Doxorubicin—liver cancer	0.00405	0.00405	CcSEcCtD
Penciclovir—Erythema—Doxorubicin—liver cancer	0.00402	0.00402	CcSEcCtD
Penciclovir—Anaemia—Epirubicin—liver cancer	0.00402	0.00402	CcSEcCtD
Penciclovir—Flatulence—Doxorubicin—liver cancer	0.00396	0.00396	CcSEcCtD
Penciclovir—Dysgeusia—Doxorubicin—liver cancer	0.00394	0.00394	CcSEcCtD
Penciclovir—Leukopenia—Epirubicin—liver cancer	0.00389	0.00389	CcSEcCtD
Penciclovir—Palpitations—Epirubicin—liver cancer	0.00384	0.00384	CcSEcCtD
Penciclovir—Anaemia—Doxorubicin—liver cancer	0.00372	0.00372	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00368	0.00368	CcSEcCtD
Penciclovir—Leukopenia—Doxorubicin—liver cancer	0.0036	0.0036	CcSEcCtD
Penciclovir—Confusional state—Epirubicin—liver cancer	0.00358	0.00358	CcSEcCtD
Penciclovir—Palpitations—Doxorubicin—liver cancer	0.00355	0.00355	CcSEcCtD
Penciclovir—Nervous system disorder—Epirubicin—liver cancer	0.00348	0.00348	CcSEcCtD
Penciclovir—Thrombocytopenia—Epirubicin—liver cancer	0.00347	0.00347	CcSEcCtD
Penciclovir—Skin disorder—Epirubicin—liver cancer	0.00345	0.00345	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.0034	0.0034	CcSEcCtD
Penciclovir—Confusional state—Doxorubicin—liver cancer	0.00331	0.00331	CcSEcCtD
Penciclovir—Nervous system disorder—Doxorubicin—liver cancer	0.00322	0.00322	CcSEcCtD
Penciclovir—Thrombocytopenia—Doxorubicin—liver cancer	0.00321	0.00321	CcSEcCtD
Penciclovir—Skin disorder—Doxorubicin—liver cancer	0.00319	0.00319	CcSEcCtD
Penciclovir—Paraesthesia—Epirubicin—liver cancer	0.00319	0.00319	CcSEcCtD
Penciclovir—Somnolence—Epirubicin—liver cancer	0.00315	0.00315	CcSEcCtD
Penciclovir—Fatigue—Epirubicin—liver cancer	0.00306	0.00306	CcSEcCtD
Penciclovir—Pain—Epirubicin—liver cancer	0.00303	0.00303	CcSEcCtD
Penciclovir—Paraesthesia—Doxorubicin—liver cancer	0.00295	0.00295	CcSEcCtD
Penciclovir—Feeling abnormal—Epirubicin—liver cancer	0.00292	0.00292	CcSEcCtD
Penciclovir—Somnolence—Doxorubicin—liver cancer	0.00292	0.00292	CcSEcCtD
Penciclovir—Gastrointestinal pain—Epirubicin—liver cancer	0.0029	0.0029	CcSEcCtD
Penciclovir—Fatigue—Doxorubicin—liver cancer	0.00283	0.00283	CcSEcCtD
Penciclovir—Urticaria—Epirubicin—liver cancer	0.00282	0.00282	CcSEcCtD
Penciclovir—Pain—Doxorubicin—liver cancer	0.00281	0.00281	CcSEcCtD
Penciclovir—Abdominal pain—Epirubicin—liver cancer	0.0028	0.0028	CcSEcCtD
Penciclovir—Feeling abnormal—Doxorubicin—liver cancer	0.0027	0.0027	CcSEcCtD
Penciclovir—Gastrointestinal pain—Doxorubicin—liver cancer	0.00268	0.00268	CcSEcCtD
Penciclovir—Hypersensitivity—Epirubicin—liver cancer	0.00261	0.00261	CcSEcCtD
Penciclovir—Urticaria—Doxorubicin—liver cancer	0.00261	0.00261	CcSEcCtD
Penciclovir—Abdominal pain—Doxorubicin—liver cancer	0.00259	0.00259	CcSEcCtD
Penciclovir—Asthenia—Epirubicin—liver cancer	0.00255	0.00255	CcSEcCtD
Penciclovir—Pruritus—Epirubicin—liver cancer	0.00251	0.00251	CcSEcCtD
Penciclovir—Diarrhoea—Epirubicin—liver cancer	0.00243	0.00243	CcSEcCtD
Penciclovir—Hypersensitivity—Doxorubicin—liver cancer	0.00242	0.00242	CcSEcCtD
Penciclovir—Asthenia—Doxorubicin—liver cancer	0.00236	0.00236	CcSEcCtD
Penciclovir—Dizziness—Epirubicin—liver cancer	0.00235	0.00235	CcSEcCtD
Penciclovir—Pruritus—Doxorubicin—liver cancer	0.00232	0.00232	CcSEcCtD
Penciclovir—Vomiting—Epirubicin—liver cancer	0.00226	0.00226	CcSEcCtD
Penciclovir—Diarrhoea—Doxorubicin—liver cancer	0.00225	0.00225	CcSEcCtD
Penciclovir—Rash—Epirubicin—liver cancer	0.00224	0.00224	CcSEcCtD
Penciclovir—Dermatitis—Epirubicin—liver cancer	0.00223	0.00223	CcSEcCtD
Penciclovir—Headache—Epirubicin—liver cancer	0.00222	0.00222	CcSEcCtD
Penciclovir—Dizziness—Doxorubicin—liver cancer	0.00217	0.00217	CcSEcCtD
Penciclovir—Nausea—Epirubicin—liver cancer	0.00211	0.00211	CcSEcCtD
Penciclovir—Vomiting—Doxorubicin—liver cancer	0.00209	0.00209	CcSEcCtD
Penciclovir—Rash—Doxorubicin—liver cancer	0.00207	0.00207	CcSEcCtD
Penciclovir—Dermatitis—Doxorubicin—liver cancer	0.00207	0.00207	CcSEcCtD
Penciclovir—Headache—Doxorubicin—liver cancer	0.00206	0.00206	CcSEcCtD
Penciclovir—Nausea—Doxorubicin—liver cancer	0.00195	0.00195	CcSEcCtD
